A study published last week in the British Medical Journal confirms earlier reports that children generally fare well against COVID-19. Looking at patients admitted to hospitals across the U.K., the in-hospital fatality rate for children and adolescents was 1%, compared to 27% when they included adults. But 11% of children admitted for COVID-19 developed MIS-C, which was more likely in minorities and kids aged 10 to 14. The children who developed this syndrome often presented with fatigue, headache, muscle aches, sore throat, and swollen lymph nodes.